S
Sierra Nevada Specialty Care | Reno, NV
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Clazakizumab
BI 690517
Metformin
Retatrutide
Empagliflozin
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...
Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300
Locations recently updated
This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study....
Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: Empagliflozin
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and ren...
Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems